Targetting Ophthalmic Therapeutics

Retinset Icon logo


  • Retinset’s mission is the research and development of ophthalmic medicines for improving the lives of those affected by neurovascular ophthalmic pathologies.
  • Retinset is a clinical-stage spin-off from MedicalMix logo(Medpoint Group S.L), a leading national company in the import and distribution of surgical ophthalmology medical devices, at the forefront of the ophthalmological field.
  • Retinset is located in Sant Cugat del Vallés (Barcelona, Spain).
  • Our leading program (BSL01) is an innovative eyedrop formulation to treat Diabetic Retinopathy (DR) since very early stages.